MIM
MNPR icon

Martin Investment Management’s Monopar Therapeutics MNPR Stock Holding History

Martin Investment Management’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+2,327
New +$144K 0.07% 47

Other funds holding MNPR

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Martin Investment Management's MNPR Position: Q2 2026 in Review

Martin Investment Management opened a new position in Monopar Therapeutics (MNPR) in Q2 2026: 2,327 shares worth $215K. The stake represents 0.07% of the portfolio and ranks #47 among its holdings.

4 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Martin Investment Management held 2,327 shares of Monopar Therapeutics worth $215K as of Q2 2026.
  • Monopar Therapeutics was a new Martin Investment Management position in Q2 2026.
  • Monopar Therapeutics made up 0.07% of Martin Investment Management's portfolio in Q2 2026, its #47 holding.
  • 4 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.